HealthTree Research

HealthTree Can Help Facilitate Your Research

Patients are eager and willing to participate in investigator-led surveys and studies. HealthTree Foundation maintains an ongoing relationship of trust with blood cancer patients that enables us to provide a significantly shortened project recruitment time — our average is 4 to 6 weeks. Schedule a call with us below to learn more!

HealthTree’s Innovative Research Approach

Types of Research We Support

Interviews - Qualitative

Qualitative interviews gather patient insights, improve patient care, and enhance research efforts. These interviews can help us prioritize research objectives as they yield crucial insights into:

  • Patient journeys
  • Unmet needs
  • Diagnosis experiences
  • Treatment decisions and experiences
  • Side effects and symptom management
  • Access to care and resources
  • Emotional and psychological impacts

Surveys - Quantitative

HealthTree can use quantitative surveys to gather structured, measurable data from patients, caregivers, and healthcare professionals.

The surveys help to:

  • Understand trends
  • Evaluate programs
  • Make research contributions
  • Measure quality of life metrics
  • Assess health literacy
  • Build clinical trial awareness

Real-World Data

Many real-world data projects and data requests can be performed via your institution’s HealthTree Registry. For projects where you might need additional support or projects that you might want to discuss with our research team, please submit a proposal and a HealthTree research team member will contact you.

Biological Samples

HealthTree helps researchers advance treatment innovations and improve scientific understanding by combining our real-world data and patient involvement with biological sample analysis.

Our Research Publications

Explore our work and discover how researchers have advanced their progress with HealthTree

Become a Part of HealthTree's Research Collaborations

“HealthTree provides an unprecedented resource for researchers in the field of myeloma and other plasma cell disorders.”

Jens Hillengass, MD, PhD

Jens Hillengass, MD, PhD

Roswell Park, Buffalo, NY